KLK3 and prostate cancer: The authors identified 410 724 men who were deemed as having undergone opportunistic screening for prostate cancer (Table 2), representing 14.62% of all men in the study cohort; as such, 65.04% of all first PSA tests in the study period [410 724 out of 631 426] were deemed to be for screening.